The FDA-approved smoking cessation pill, varenicline, has emerged as a game-changing solution for those struggling with nicotine addiction, especially among teens and young adults.Recent research from Harvard-affiliated Mass General Brigham has revealed that young individuals using varenicline are three times more likely to successfully quit vaping than their peers on placebo.